Gabelli Funds LLC Has $8.56 Million Position in Option Care Health, Inc. $OPCH

Gabelli Funds LLC cut its stake in Option Care Health, Inc. (NASDAQ:OPCH) by 36.8% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 318,100 shares of the company’s stock after selling 185,210 shares during the quarter. Gabelli Funds LLC’s holdings in Option Care Health were worth $8,563,000 at the end of the most recent quarter.

A number of other hedge funds have also modified their holdings of the company. Durable Capital Partners LP grew its holdings in Option Care Health by 134.2% during the second quarter. Durable Capital Partners LP now owns 8,237,577 shares of the company’s stock valued at $267,557,000 after purchasing an additional 4,720,988 shares during the period. Southpoint Capital Advisors LP bought a new position in shares of Option Care Health during the fourth quarter worth $95,580,000. Sumitomo Mitsui Trust Group Inc. acquired a new position in shares of Option Care Health in the 1st quarter valued at $70,287,000. Norges Bank bought a new stake in shares of Option Care Health in the 4th quarter valued at $61,787,000. Finally, Van Berkom & Associates Inc. bought a new stake in shares of Option Care Health in the 1st quarter valued at $42,739,000. 98.05% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling

In other news, Director Timothy P. Sullivan bought 24,154 shares of the company’s stock in a transaction that occurred on Thursday, May 7th. The shares were acquired at an average price of $20.69 per share, with a total value of $499,746.26. Following the transaction, the director owned 73,383 shares in the company, valued at $1,518,294.27. This represents a 49.06% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Harry M. Jansen Kraemer, Jr. bought 36,610 shares of the business’s stock in a transaction on Monday, May 4th. The stock was purchased at an average price of $21.41 per share, for a total transaction of $783,820.10. Following the purchase, the director directly owned 450,000 shares in the company, valued at approximately $9,634,500. This represents a 8.86% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Over the last three months, insiders bought 73,264 shares of company stock worth $1,548,316. 1.70% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

A number of research analysts have issued reports on the company. The Goldman Sachs Group began coverage on Option Care Health in a research note on Monday, June 8th. They issued a “neutral” rating and a $22.00 target price for the company. Barrington Research dropped their price target on Option Care Health from $42.00 to $32.00 and set an “outperform” rating on the stock in a research report on Friday, May 1st. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating and set a $26.00 price objective on shares of Option Care Health in a report on Friday, May 1st. Weiss Ratings lowered Option Care Health from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Thursday. Finally, Morgan Stanley set a $28.00 target price on Option Care Health in a research note on Wednesday, May 6th. Eight equities research analysts have rated the stock with a Buy rating, five have given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, Option Care Health presently has an average rating of “Moderate Buy” and an average price target of $30.08.

Option Care Health Price Performance

OPCH stock opened at $21.66 on Monday. The stock has a 50-day moving average price of $21.32 and a two-hundred day moving average price of $27.09. The stock has a market cap of $3.40 billion, a PE ratio of 16.79, a price-to-earnings-growth ratio of 1.20 and a beta of 0.65. The company has a current ratio of 1.64, a quick ratio of 1.07 and a debt-to-equity ratio of 0.85. Option Care Health, Inc. has a 1 year low of $18.01 and a 1 year high of $36.80.

Option Care Health (NASDAQ:OPCH) last released its quarterly earnings results on Thursday, April 30th. The company reported $0.40 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.37 by $0.03. The firm had revenue of $1.35 billion for the quarter, compared to the consensus estimate of $1.39 billion. Option Care Health had a return on equity of 18.17% and a net margin of 3.64%.The company’s revenue for the quarter was up 1.3% on a year-over-year basis. During the same quarter last year, the business posted $0.40 EPS. Option Care Health has set its FY 2026 guidance at 1.820-1.920 EPS. Equities analysts forecast that Option Care Health, Inc. will post 1.64 EPS for the current fiscal year.

About Option Care Health

Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.

Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry’s most experienced home infusion businesses.